ASSOCIATION BETWEEN PLASMA TRANSFUSION AND IN-HOSPITAL MORTALITY IN CRITICALLY ILL PATIENTS WITH SEPSIS-INDUCED COAGULOPATHY

被引:3
作者
Wang, Renli [1 ,3 ]
Liu, Rongjun [2 ]
Xu, Zhaojun [1 ,3 ]
机构
[1] Ningbo 2 Hosp, Dept Intens Care Unit, Ningbo, Zhejiang, Peoples R China
[2] Ningbo 2 Hosp, Dept Anesthesiol, Ningbo, Zhejiang, Peoples R China
[3] Ningbo 2 Hosp, Dept Intens Care Unit, 41 Northwest St, Ningbo 315010, Zhejiang, Peoples R China
来源
SHOCK | 2023年 / 60卷 / 04期
关键词
Plasma infusion; sepsis-induced coagulopathy; in-hospital mortality; MIMIC-IV; DISSEMINATED INTRAVASCULAR COAGULATION; TISSUE FACTOR; THROMBOSIS; DIAGNOSIS;
D O I
10.1097/SHK.0000000000002209
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background:Plasma is commonly used in patients with coagulopathy; however, its role in patients with sepsis-induced coagulopathy (SIC) is unclear. This study aimed to evaluate the effect of plasma transfusion on the prognosis of patients with SIC. Methods:Data were collected from the Medical Information Mart for Intensive Care IV database. Multivariable logistic regression analysis was used to determine the association between plasma transfusion and the incidence of in-hospital mortality, pulmonary embolism, and lower extremity deep vein thrombosis in critically ill patients with SIC. Propensity score matching (PSM) and propensity score-based inverse probability of treatment weighting (IPTW) models were used to ensure the robustness of our findings. Furthermore, the nonparametric relationship between in-hospital mortality and plasma transfusion volume was analyzed using restricted cubic spline. Subgroups analyses were performed for age, sex, Charlson score, Sequential Organ Failure Assessment score, SIC score, and with hemorrhage. Results:A total of 8,747 patients with SIC were enrolled: of them, 1874 were in the plasma infusion group, and 6,873 were in the no plasma infusion group. Compared with the no plasma infusion group, the plasma infusion group had higher in-hospital mortality (odds ratio [OR], 1.4411; 95% confidence interval [CI], 1.2280-1.6897, P < 0.05), and the results were robust after PSM (OR, 1.3227; 95% CI, 1.1152-1.5697; P < 0.05) and IPTW (OR, 1.1541; 95% CI, 1.0738-1.2404; P < 0.05). Similar results were also observed in different subgroups. However, because of conflicting results after PSM and IPTW, we were unable to definitively link plasma transfusion with pulmonary embolism and deep vein thrombosis. Compared with the no early plasma transfusion group (>= 12 h), the in-hospital mortality rate was lower in the early plasma transfusion group (<12 h) (OR, 0.5426; 95% CI, 0.4398-0.6844; P < 0.05). The restricted cubic spline analysis indicated that increased plasma transfusion was associated with increased in-hospital mortality in patients with SIC. Conclusion:Plasma transfusion increases in-hospital mortality in patients with SIC, and the mortality rate increases with the amount of plasma transfusion. Patients with SIC who received early plasma infusion had lower in-hospital mortality than those who received no early plasma transfusion.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 36 条
  • [1] Transfusion utilization during adnexal or peritoneal cancer surgery: Effects on symptomatic venous thromboembolism and survival
    Abu-Rustum, NR
    Richard, S
    Wilton, A
    Lev, G
    Sonoda, Y
    Hensley, ML
    Gemignani, M
    Barakat, RR
    Chi, DS
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 99 (02) : 320 - 326
  • [2] Diagnosis and treatment of disseminated intravascular coagulation: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
    Di Nisio, Marcello
    Baudo, Francesco
    Cosmi, Benilde
    D'Angelo, Armando
    De Gasperi, Andrea
    Malato, Alessandra
    Schiavoni, Mario
    Squizzato, Alessandro
    [J]. THROMBOSIS RESEARCH, 2012, 129 (05) : E177 - E184
  • [3] Sepsis and septic shock in France: incidences, outcomes and costs of care
    Dupuis, Claire
    Bouadma, Lila
    Ruckly, Stephane
    Perozziello, Anne
    Van-Gysel, Damien
    Mageau, Arthur
    Mourvillier, Bruno
    de Montmollin, Etienne
    Bailly, Sebastien
    Papin, Gregory
    Sinnah, Fabrice
    Vinclair, Camille
    Abid, Sonia
    Sonneville, Romain
    Timsit, Jean-Francois
    [J]. ANNALS OF INTENSIVE CARE, 2020, 10 (01)
  • [4] Thrombin during cardiopulmonary bypass
    Edmunds, L. Henry, Jr.
    Colman, Robert W.
    [J]. ANNALS OF THORACIC SURGERY, 2006, 82 (06) : 2315 - 2322
  • [5] Evans L, 2021, INTENS CARE MED, V47, P1181, DOI [10.1007/s00134-021-06506-y, 10.1097/CCM.0000000000005337]
  • [6] Assessment of Global Incidence and Mortality of Hospital-treated Sepsis
    Fleischmann, Carolin
    Scherag, Andre
    Adhikari, Neill K. J.
    Hartog, Christiane S.
    Tsaganos, Thomas
    Schlattmann, Peter
    Angus, Derek C.
    Reinhart, Konrad
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (03) : 259 - 272
  • [7] Role of blood transfusion product type and amount in deep vein thrombosis after cardiac surgery
    Ghazi, Lama
    Schwann, Thomas A.
    Engoren, Milo C.
    Habib, Robert H.
    [J]. THROMBOSIS RESEARCH, 2015, 136 (06) : 1204 - 1210
  • [8] Tissue factor on the loose
    Giesen, PLA
    Nemerson, V
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04) : 379 - 384
  • [9] REGRESSION-MODELS IN CLINICAL-STUDIES - DETERMINING RELATIONSHIPS BETWEEN PREDICTORS AND RESPONSE
    HARRELL, FE
    LEE, KL
    POLLOCK, BG
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (15) : 1198 - 1202
  • [10] Derangement of the endothelial glycocalyx in sepsis
    Iba, T.
    Levy, J. H.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (02) : 283 - 294